Trial · NCT07914647
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adverse events and serious adverse events | From enrolment to the end of the study at 24 weeks | Measures of safety associated with the intervention |
| Primary | Acceptability | From enrolment to end of study at 24 weeks | Likert scale (1= none; 5 = extremely severe) rating of symptoms related to RIC via treatment logs. Less than a third of participants reporting at least moderate discomfort (mean score ≥ 3), as well as from qualitative semi-structured interviews with participants completing the study. |
| Primary | Compliance | From enrolment to end of study at 24 weeks | = \> 80% intended treatment sessions completed. |
| Secondary | Fatigue Severity Score | From enrolment to end of treatment at 12 weeks | Mean change in FSS from baseline to end of treatment will be recorded. |
| Secondary | Modified Fatigue Impact Scale | From enrolment to end of treatment at 12 weeks | MFIS is a secondary measure of fatigue used to characterise fatigue symptom profiles |
| Secondary | Barthel Index | From enrolment to end of treatment at 12 weeks | The Barthel Index is a clinical assessment tool that measures a patient's level of functional independence in basic activities of daily living (ADLs) and mobility |
| Secondary | Modified Rankin Score | From enrolment to end of treatment at 12 weeks | a 7-point clinical tool used to measure the degree of disability or dependence in daily activities for patients who have suffered a stroke or other neurological conditions. |
| Secondary | Generalised Anxiety and Depression Score | From enrolment to end of treatment at 12 weeks | Measure of Anxiety |
| Secondary | Physical Health Questionnaire 9 | From enrolment to end of treatment at 12 weeks | Measure of Depression |
| Secondary | Stroke Impact Scale | From enrolment to end of treatment at 12 weeks | Stroke Specific Quality of Life Measure |
| Secondary | EQ-5D | From enrolment to end of treatment at 12 weeks | Measures Quality of Life |
| Secondary | 6 Minute Walk Test | From enrolment to end of treatment at 12 weeks | a clinical exercise test that measures the total distance a person can walk on a flat, hard surface over a 6-minute |
| Secondary | Daily Step Count | From enrolment to end of treatment at 12 weeks | Measure of activity |
| Secondary | Maximal oxygen uptake (VO2 max) | From enrolment to end of treatment at 12 weeks | Measure of exercise performance |
| Secondary | Muscle resting state ATP (MR Spectroscopy) | From enrolment to end of treatment at 12 weeks | to evaluate cellular energy metabolism and measure high-energy phosphates |
| Secondary | Interleukin 1-beta | From enrolment to end of treatment at 12 weeks | Inflammatory mediator |
| Secondary | Interleukin 6 | From enrolment to end of treatment at 12 weeks | Inflammatory mediator |
| Secondary | Interleukin 10 | From enrolment to end of treatment at 12 weeks | Anti -inflammatory mediator |
| Secondary | Tumor Necrosis Factor Alpha | From enrolment to end of treatment at 12 weeks | Inflammatory mediator |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07914647/registered